Allergen‐Specific Human Monoclonal IgG Antibodies for Use in Passive Allergy Immunotherapy

作者
Scott A. Smith,Cosby A. Stone,Alain Jacquet
出处
期刊:Clinical & Experimental Allergy [Wiley]
标识
DOI:10.1111/cea.70153
摘要

The last decades have shown the number of subjects developing allergic rhinitis (AR), allergic asthma (AA), atopic dermatitis (AD), and food allergy rose continuously worldwide. To cure these allergic diseases, allergen-specific immunotherapy (AIT) represents the unique treatment capable of providing clinical outcomes through the induction of long-term immunological tolerance. Despite proven efficacy, the duration of treatment, AIT-associated side effects, and the difficulty in identifying potential responders by diagnosis lead to poor patient compliance. Clinical investigations evidenced the role of blocking IgG antibodies induced by AIT in long-term tolerance. These observations suggested that passive allergy immunotherapy (PAIT) with low doses of allergen-specific blocking IgG antibodies represents an elegant alternative to frequent administrations of allergen extracts. Tremendous technological progress in the discovery/production of fully human monoclonal antibodies (mAbs) with very low immunogenicity has been made in the last decades, and these therapeutic antibodies revolutionised the treatment of cancers or infectious diseases. The recent advances in the isolation of rare allergen-specific IgE+ B cells and the generation of human antibodies in transgenic mice made possible the production of human monoclonal blocking antibodies against any allergen, sharing the same affinity with the corresponding naturally occurring IgE. This comprehensive review will describe the first promising preclinical and clinical data obtained with antibody cocktails targeting several IgE epitopes to some key single allergens. PAIT is safe and effective for the downregulation of the allergic response. Compared with conventional extract-based AIT, the positive outcomes could require much less dosing.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
赘婿的应助被guzhi采纳,获得30
1秒前
打打的应助被采一采纳,获得10
1秒前
1秒前
现代秋天发布了新的文献求助10
1秒前
康谨发布了新的文献求助10
2秒前
2秒前
2秒前
miaomao完成签到,获得积分10
2秒前
2秒前
3秒前
娇妹儿完成签到,获得积分10
4秒前
yuyanqiao完成签到,获得积分10
4秒前
4秒前
5秒前
yzq发布了新的文献求助10
5秒前
在水一方的应助被611采纳,获得10
5秒前
田国兵完成签到,获得积分10
6秒前
薇子完成签到,获得积分10
6秒前
雨安完成签到,获得积分10
6秒前
Doctor发布了新的文献求助10
6秒前
7秒前
8秒前
苦瓜发布了新的文献求助10
8秒前
上官若男的应助被难过的谷芹采纳,获得10
8秒前
9秒前
Akim的应助被小little采纳,获得10
10秒前
lanzhihe322发布了新的文献求助10
10秒前
脑洞疼的应助被泡泡采纳,获得10
11秒前
CAR-T DOG发布了新的文献求助10
11秒前
12秒前
12秒前
12秒前
Parker发布了新的文献求助30
12秒前
加减乘除发布了新的文献求助10
12秒前
13秒前
13秒前
yzq完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194239
求助须知:如何正确求助?哪些是违规求助? 9580103
关于积分的说明 21869458
捐赠科研通 7793840
什么是DOI,文献DOI怎么找? 3437562
关于科研通互助平台的介绍 2560983
邀请新用户注册赠送积分活动 2484332